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Abstract 
Background: Burned patients are a special fragile population in which 
infections are a leading cause of dead and morbidity. Fungal infections have 
become increasingly prevalent in Intensive Care Units (ICU) and burn ICUs. 
Management of fungal colonization and infection still constitutes a challenge for 
clinicians. 
Aim: characterize the population of burn patients with fungal infections admitted 
in our Burn ICU. 
Methods: a retrospective cross-sectional study of all patients admitted to a Burn 
ICU between 2013 and 2015. 172 patients were included and characterized 
regarding age, gender, date of admission and exit, type of burn, type of exit, 
burned Total Body Surface Area (TBSA) and presence of inhalation injury. 
Presence of fungal infection, causative pathogen and site of sampling were also 
registered. Statistical analysis centred around the presence of fungal infection 
was performed using IBM SPSS Statistics. 
Results: 172 patients were included, 38 (22,1%) had a fungal infection and 
from this 8 (21,1%) died. Patients with fungal infection stayed more days than 
those without infection. However, this tendency didn’t reach statistical 
significance when patients that died on ICU where excluded. No relations were 
found when comparing fungal infection with TBSA, burn aetiology, inhalation 
injury or mortality. 
Conclusion: fungal infection are a major cause of morbidity and mortality 
despite of TBSA, burn type or presence of inhalation injury. Efforts should be 
made to improve management of fungal infections, especially on burn patients 
and other critically ill groups. 
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Introduction 
Infections are a worldwide health problem, with burned patients at a high 
risk of infection, due to their complexity and fragility. In critically ill patients, they 
constitute a major cause of morbidity and mortality.1-3 In this group, infections 
are also a leading cause of dead and morbidity, being burn wound infection 
(BWI) a major public health problem and one of the most devastating traumas.4-
7 
Infections in burned patients are mainly caused by bacteria, followed by 
fungi and then viruses.3 Due to the fungi ubiquity and the widespread antibiotic 
use, fungal infections have become an increasing problem over the past few 
years.3-6,8-10 This type of infections account for approximately 20% of all 
infections in Intensive Care Units1 (ICU), and in the burn patients scenario the 
situation is similar, representing 6-26% of infections according to some 
studies.3,5-7,10,11 
This usually occur around or after the second week of burn injury, in 
patients who received or are taking antibiotics.10 These infections are also 
known to be associated with inhalation injury and higher burned Total Body 
Surface Area (TBSA), as well as with diabetes or total parental nutrition (NTP) 
in severe burned patients.5,6,8,11 
Despite some attention in the recent years, fungal infections still 
constitute a challenge in burned patients management, mainly due to delayed 
diagnosis and difficulties in fungi culture and its sensitivity6,8-10, and have been 
described as contributors to burn wound progression.3 Further than that, fungal 
infections are known to be associated to higher morbidity and mortality 
rates.5,6,11 Although aggressive empiric treatment is not preconized, some 
authors defend it should be.5 
The aim of this study was to determine the incidence of fungal infections in 
burned patients admitted in our Burn ICU between 2013 and the end of 2015 
and to characterize this population. 
  
Methods 
2.1. Study Design 
 This is a cross sectional study, done retrospectively, regarding fungal 
infections on burned patients admitted to a Burn ICU. 
 
2.2. Study setting 
All patients admitted to the Centro Hospitalar São João (CHSJ) Burn ICU 
during the years 2013–2015 have been analysed. The CHSJ Burn ICU is one of 
the main burn units in Portugal and is associated with the Plastic and 
Reconstructive Surgery Department. All data was obtained from medical 
records retrieved retrospectively from paper records and a computerized, 
hospital-wide database, during the first trimester of 2019. 
 
2.2. Assessment and management of burn patients 
In our unit, the extent of burns is calculated by assessing the percentage 
of total body surface area (TBSA), according to the Lund and Browder chart.  A 
patient admitted to the Burn ICU gets samples collected for microbiology 
analysis at the entrance moment. After this, every week during ICU stay blood 
cultures and urinary sample, skin swaps, skin biopsies or respiratory secretions 
are collected depending on infection suspicion by the clinicians. 
Once blood culture results are obtained and resistance profile analysed, 
antibiotic or antifungal treatment is adjusted accordingly. The Burn ICU works in 
collaboration with a Group for Hospital Management of Infections and 
Treatment in order to define an appropriate treatment strategy. 
 
 
2.3. Procedures 
The study period was 3 years (2013-2015). Data of all patients admitted to 
the Burn ICU between this interval was retrieved, including age, gender and date 
of admission and exit, used for calculating the total time of stay in the Burn ICU. 
Type of burn (6 different groups: “Fire”, “Chemical”, “Electrical”, “Scald 
burn” (“Hot fluids”), “Toxic skin syndromes” and “More than one”) and type of exit 
from the Burn ICU (alive discharge vs death) were recorded. TBSA and Presence 
of inhalation injury were also registered. 
Patients with a Toxic epidermal necrolysis (TEN) and other Toxic skin 
syndromes as well as the ones with multiple causes of burn were excluded from 
the analysis. 
Regarding fungal infection patients who had at least one positive sample 
for fungal infection during their stay in the Burn ICU were identified. If a patient 
had more than one sample positive to fungal infection, only the first isolation 
was registered and used in the analysis. 
Cause of infection was also registered in 6 groups (Candida albicans, 
Candida non-albicans, Aspergillus spp., Fusarium spp., Zygomycetes and Other 
or non-identified) and the source of the sample was as well registered and 
grouped (4 groups: Wound/Soft tissues, Urinary sample, Respiratory secretions, 
Blood culture). 
 
2.4. Statistical Analysis 
 Statistical analysis was performed using IBM SPSS Statistics® version 
23.0, with 0.05 as a significance level. T-test was used to identify differences in 
age, time of stay and TBSA according to the presence of fungal infection and to 
mortality. Qui-square or Fisher exact test were used to identify an association 
between the presence of fungal infection and the other qualitative variables. 
Mean and standard deviation were used for quantitative data, and absolute and 
relative frequencies for qualitative variables. 
  
Results 
 
3.1. Descriptive Data 
 Between 2013 
and 2015, one hundred 
and seventy-eight (178) 
patients were admitted 
in the CHSJ Burn ICU 
unit. Of these, 172 
patients were selected 
for this study, 116 
(67,4%) were men and 
56 (32,6%) women. 
(Figure 1). The mean 
patients age was 51.65 years, ranging from 12 to 94 years. (Table 1) 
 
The time of stay was in average 24 days (24,58 days) in the ICU. (Table 
1). Forty-one (41 - 23,8%) patients had inhalation injury and 28 (16,3%) died in 
the Burn ICU. The most frequent cause of burn was fire (125 - 72,7%), followed 
by scald burns (17,4%), electrical burns (7%) and chemical (2,9%). (Figure 2) 
The mean TBSA was 23,18%. 
 
 
Thirty-eight patients 
(22,1%) had a fungal infection 
in the Burn ICU, from which 
21,1% (n=8) died. (Table 2) 
Non-albican candidas 
were the most common isolated 
microorganisms in 20 patients 
(52,6%), followed by candida 
albicans (15 patients - 39,5%), 
aspergillus spp. (1 patient – Figure 2 – Distribution according to Type 
of Burn 
Figure 1 – Population Characteristics 
2.6%) and not identified agents (2 cases – 5.3%). Most fungi isolations were 
obtained from soft tissue samples (23 cases - 60,5%), followed by urinary 
samples (23,7%) and finally blood cultures and respiratory secretions samples 
(7,9% each) (Figure 3) 
 
 
 
 
3.1. Main Results 
When comparing with patients with alive discharges from ICU, time of 
stay was less in the patients who died on ICU (15,04 vs 26,43, p=0,012), while 
age and TBSA were higher in this group (62,07years vs 49,62years and 57,26% 
vs 16,51%, respectively), all these results reaching statistical significance. 
Was detected, with statistical significance, that the patients with fungal 
infection stayed more days than those without infection (32,76 vs 22,25 days, 
p=0,031). However, when patients that died on ICU were taken out of analysis, 
the analysis was short for statistical significance, despite being observed the 
same tendency (32,77 vs 24,76 days). 
Figure 3 – Distribution of fungi infected patients according to fungal aetiological agent and to 
sample isolation source 
Regarding TBSA, there was no statistically significant differences 
between those with and without fungal infection. (Table 1) 
 
 
 
 
Comparing the patients with fungal infection with those without, we didn’t 
find any statistically significant differences regarding mortality or the presence of 
inhalation injury. However, a tendency for higher mortality was seen on those 
patients with fungal infection (21,1% vs 14,9%). 
Similarly, no differences between groups were found when aetiology of 
burn or TBSA categories were analysed. Fire burns were the most common 
type in both groups, and the TBSA groups distribution was similar regardless of 
presence of fungal infection. (Table 2) 
 
 
 
 
Discussion 
 Extensive thermal injury, seen in burned patients admitted in an 
Intensive Care Unit, results in severe cardiovascular, end-organ perfusion and 
immune derangement, known as Burn Shock. These patients exhibit a clinical 
picture marked by systemic inflammation, described as systemic inflammatory 
response syndrome (SIRS), mostly caused by the tissue damaged by the burn. 
This is associated with burn induced immunosuppression which facilitates 
pathogens colonization and infection.12,13 Infection may lead to sepsis, a major 
cause of morbidity and also mortality, accounting for the majority of deaths in 
burn patients.4-7,12-15 
Burn wounds provide an optimal environment for bacterial growth, due to 
deficient perfusion and nutrient rich conditions. Normally, colonization ensues 
by environment, gut and oropharyngeal track pathogens, being gram positive 
bacteria the first to colonize followed by gram negative bacteria, colonization by 
fungi usually occurs later on.2,12 
The incidence of fungal infections was of 22.1%, which is similar to other 
studies around the world with incidences ranging from 26% to 44% 5,6,9-11, but 
contrasting with the other works with incidence ranging from 6% to 10%, 
including a multicentre American Burn Association review (ABA)8,16 
 
Fungal infection have become increasingly prevalent following broad-
spectrum antimicrobial use and given the ubiquity of fungi and fragility of burned 
patients.4,6,8,10,12,13 Most frequently, fungi come from environment as burn 
patients roll on the floor to extinguish flames, use current water to wash 
chemical and fire burns and use contaminated bandaging left open on air. Other 
environmental foci described are air conditioning vents and floor drains. Often 
infection arises from the patient’s own flora.12  
Fungal infections are associated with high morbidity and mortality rates in 
burned patients, regardless of TBSA inhalation injury or age as described in 
other works.2,4,9-12 Despite this we didn’t find a statistically significant between 
fungal infection and mortality. 
This study detected, with statistical significance, a higher time of stay 
among the patients with fungal infection, such relation is also seen in other 
studies.7,8,11 When patients death on ICU were taken out of analysis this relation 
didn’t reach statistical significance. The timing of infection by fungi may explain 
this, as some studies have shown that fungal infection commonly appear after 2 
- 4 weeks of hospitalization2,5,6,10, patients who died short after admission in ICU 
might not have the time to get infected by fungi. 
Most commonly, according to some literature, fungi isolation are obtained 
from wound/soft tissues samples, followed by urinary samples and respiratory 
secretions and lastly from blood cultures, this pattern meets our findings 
regarding sample sites11,16 We also find candida spp. to be the most common 
pathogens causing fungal infection, which was also reported in multiple 
studies5,6,8,10,13 
Some studies described an association of TBSA with fungal infection, 
with mainly TBSA between 30% and 60% being associated with higher fungal 
infections rate.5,6,10,11 Our findings don’t support this association, with no 
statistically significant relation being found between fungal infection and TBSA 
(either normal and grouped). 
The management of fungal infections presents as a challenge. The 
diagnostic of fungi colonization and infection isn’t easy as routine culture 
techniques require around 7 to 14 days and venous blood culture sometimes 
fail to reflect the fungal agent. This leads to a delay in treatment initiation and 
complicates fungal infection management.6,10,12 Antifungal treatment itself is 
difficulted by toxicities and limited treatment options. Fluconazole is the most 
common antifungal agent, other azoles, amphotericin B and echinocandins are 
other options. Wound closure with autographs and early burned tissue 
debridement remain the most successful treatment options.4,11,12 
Although this study includes a database of 172 patients, a bigger population 
could have been used, expanding the time of study, that could reveal other 
findings that our study fell short in demonstrating. Temporal recording of fungal 
infection diagnosis on the Burn ICU would have shown some interesting data 
regarding fungal infections timing on hospitalized patients. Moreover, more 
variables as treatment agent and patients risk factors (e.g. diabetes mellitus, 
heart failure, autoimmune diseases, etc.) that weren’t analysed because of lack 
of data may be important to better understand and characterize fungal 
infections in burned patients. 
 
Conclusions 
Despite not reaching statistical significance as in other works, a tendency 
for higher mortality among patients with fungal infections was seen. Fungal 
infections didn’t seem to be related to TBSA, burn type or presence of inhalation 
injury. Diagnosis and treatment of fungal infections have a lot of setbacks that 
difficult approach to this important problem, 
This emphasizes the need for better tools (either on early diagnosis and 
treatment agents) for fungal infection management, especially in critically ill 
groups as the burn patients, as it represents a high burden problem in this 
group.  
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Legends 
Figure 1 – Population Characteristics 
Figure 2 – Distribution according to Type of Burn 
Figure 3 – Distribution of fungi infected patients according to fungal aetiological 
agent and to sample isolation source 
Table 1 – Relation of Fungal Infection and Mortality with age, time of stay (total 
and excluding dead patients) and TBSA. 
Table 2 – Relation of Fungal Infection with mortality, inhalation injury, aetiology 
of burn and TBSA categories. 
 
  
Total sample 
 Fungal Infection  Mortality 
      with without p value   Death Discharge p value 
Age (years)          
 Mean 51,65  55,74 50,49 
0,152 
 62,07 49,62 
0,002  SD 19,94  21,51 19,40  20,68 19,22 
Time of Stay         
 Mean 24,58  32,76 22,25 
0,031 
 15,04 26,43 
0,012  SD 21,95  27,27 19,70  26,20 20,63 
Time of Stay (excluding patients dead on ICU)      
 Mean 26,43  32,77 24,76 
0,058 
 --- 26,43 
---  SD 20,63  22,84 19,77   20,63 
TBSA          
 Mean 23,18  23,58 23,06 
0,905 
 57,26 16,51 
<0,001 
  SD 23,23   22,17 23,61   30,46 14,01 
 
 
Table 1 – Relation of Fungal Infection and Mortality with age, time of stay (total and excluding dead patients) and TBSA. 
 Table 2 – Relation of Fungal Infection with mortality, inhalation injury, aetiology of burn and TBSA categories. 
     Presence of Fungal Infection  
  Total   with without  
  n %  n % n % p value 
Fungal Infection Yes 38 (22,1%)             
  No 134 (77,9%)             
Mortality Discharged 144 (83,7%)   30 (78,9%) 114 (85,1%) 0,366 
  Death 28 (16,3%)   8 (21,1%) 20 (14,9%) 
Inhalation Injury No inhalation injury 131 (76,2%)   29 (76,3%) 102 (76,1%) 0,980 
  Inhalation injury 41 (23,8%)   9 (23,7%) 32 (23,9%) 
Aetiology of Burn Fire 125 (72,7%)   29 (76,3%) 96 (71,6%) 
0,784  Electricity 12 
(7,0%)  1 (2,6%) 11 (8,2%) 
 Chemical 5 (2,9%)  1 (2,6%) 4 (3,0%) 
  Scald 30 (17,4%)   7 (18,4%) 23 (17,2%) 
TBSA (categories) < 30% 122 (70,9%)   28 (73,7%) 94 (70,1%) 
0,635  30 - 59% 25 
(14,5%)  4 (10,5%) 21 (15,7%) 
 ≥ 60% 18 (10,5%)  5 (13,2%) 13 (9,7%) 
  missing 7 (4,1%)   1 (2,6%) 6 (4,5%) 
ANEXOS 
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